Published in Biotech Business Week, January 22nd, 2007
The company sold 5,305,557 shares of common stock at $1.80 per share for aggregate gross proceeds of $9.55 million. Participants in the financing included several new institutional investors as well as existing investors and affiliates of Sigma-Tau Group, the company's largest stockholder. In addition, warrants to purchase 2,122,222 shares of common stock were issued to the investors. The warrants have an exercise price of $2.75 per share. Piper Jaffray & Co. acted as sole placement agent for the transaction.
"We are pleased that several of our existing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.